Marketplace Dynamics: HIV

Marketplace Dynamics: HIV assesses current and future access landscapes for HIV treatments to support effective identification of opportunities and risks for brands.

  • What level of influence do payers and organized providers have on access in the HIV treatments market?

  • How will payer and organized provider management and contracting for branded HIV drugs evolve over the next two years, and how should companies prepare for these changes?

  • How are payers responding to key events in the HIV drugs market, such as new approvals and updated clinical data?

Use Marketplace Dynamics: HIV to:

  • Closely monitor market evolution
  • Recognize access shifts across the payer and organized provider segments
  • Assess/predict current and future payer management of the HIV drugs market to develop effective strategies for inline/pipeline brand(s)
  • Identify risks for brands, along with opportunities to improve access
  • Overview and Access Influencers March
    • Road map for improving HIV brand access in 2020
    • Cross-category analysis of prioritization and management of drugs
    • Analysis of management of the HIV market
    • Advocacy group influence on health plan management of HIV drugs
  • Insights on Brand Access at Payers in 2020 April
    • Payer use of reimbursement and utilization management tactics, along with protocols, to influence drug use and restrict access of branded HIV drugs
    • Evolving management strategies for branded HIV drugs on the medical benefit
    • Brand-specific line-of-therapy requirements across HIV indications
  • Organized Provider Management and Evolving Alternative Payment Models June
    • Organized provider use of management tools and tactics to guide drug use and specialist treatment decisions
    • Prevalence of alternative payment models, innovative financial incentives, and performance metrics, and associated impacts on drug access
  • Contracting Trends and Insights July
    • Impact and prevalence of contracting within the HIV drugs market
    • Key contracting terms and factors driving access gains for branded HIV drugs
    • Evolution of risk-based contracting agreements for branded HIV drugs
  • Outlook and Insights on Brand Access in 2023 September
    • Evolution of access in the branded HIV drugs market
    • Predicted payer and organized provider management tactics for HIV drugs by 2023
    • Brand access predictions for particular scenarios
This product may also include relevant market alerts, real-time assessments of recent changes, or market events. EVERSANA reserves the right to change the timing and/or topics of its syndicated research publications.

Interested in a product?

Contact Us

  • This field is for validation purposes and should be left unchanged.